Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis
- 1 February 2003
- journal article
- case report
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 125 (2) , 426-427
- https://doi.org/10.1067/mtc.2003.140
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Infusion of methylene blue in human septic shock: A pilot, randomized, controlled studyCritical Care Medicine, 2001
- Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?The Journal of Thoracic and Cardiovascular Surgery, 2000
- Heparin Neutralization with Methylene Blue, Hexadimethrine, or Vancomycin After Cardiopulmonary BypassAnesthesia & Analgesia, 1996
- Methylene blue increases myocardial function in septic shockCritical Care Medicine, 1995
- Effect of septic serum on vascular smooth muscleCritical Care Medicine, 1992